Athira Pharma Ownership | Who Owns Athira Pharma?


OverviewForecastFinancialsChart

Athira Pharma Ownership Summary


Athira Pharma is owned by 11.57% institutional investors, 13.37% insiders, and 75.07% retail investors. Vanguard group is the largest institutional shareholder, holding 3.90% of ATHA shares. Simplify Propel Opportunities ETF is the top mutual fund, with 3.79% of its assets in Athira Pharma shares.

ATHA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAthira Pharma11.57%13.37%75.07%
SectorHealthcare Stocks 232.51%10.72%-143.23%
IndustryBiotech Stocks 384.56%10.58%-295.14%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group153.79K3.90%$1.16M
Simplify asset management149.28K3.79%$1.13M
Propel bio management149.28K3.79%$1.13M
Renaissance75.15K1.91%$568.86K
Blackrock676.24K1.76%$1.79M
Jacobs levy equity management506.81K1.32%$1.34M
Pathstone38.61K0.98%$278.90K
Blackrock funding, inc. /de37.64K0.95%$284.96K
Acadian asset management37.48K0.95%$282.00K
Geode capital management30.94K0.78%$234.31K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Propel bio management149.28K0.96%$1.13M
Simplify asset management149.28K0.02%$1.13M
Invst27.00K0.01%$67.77K
Jacobs levy equity management506.81K0.01%$1.34M
Pathstone38.61K0.00%$278.90K
Renaissance75.15K0.00%$568.86K
American capital advisory200.000.00%$1.51K
Acadian asset management37.48K0.00%$282.00K
Lindbrook capital8.92K0.00%$5.23K
Public employees retirement system of ohio7.43K0.00%$19.68K

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp49.28K-30.93K
Invst27.00K0.01%27.00K
Renaissance75.15K0.00%23.22K
Jane street group13.19K-13.19K
Jacobs levy equity management506.81K0.01%9.34K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors---5.40M
Baker bros. advisors lp---3.15M
Wasatch advisors lp---1.30M
Tang capital management---600.00K
Bml capital management---323.07K

New Positions

HolderShares% AssetsChangeValue
Invst27.00K0.01%27.00K$67.77K
Jane street group13.19K-13.19K$99.82K
Group one trading69.00-69.00$522.00

Sold Out

HolderChange
Citigroup-1.00
Barclays-7.00
Global retirement partners-52.00
Householder group estate & retirement specialist-150.00
Mather group, llc.-175.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20259-72.73%456,122-73.32%110.62%1-66.67%1-96.67%
Sep 30, 20251-97.92%52-100.00%----100.00%1-83.33%
Jun 30, 202550-7.41%17,507,224-0.33%442.21%1788.89%6-66.67%
Mar 31, 202553-5.36%17,520,697-2.34%442.07%10-16.67%18-14.29%
Dec 31, 202454-8.47%17,895,38910.96%462.65%12-52.00%2150.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Simplify Propel Opportunities ETF1.49M3.79%-
Vanguard US Total Market Shares ETF1.12M2.87%-
Vanguard Total Stock Mkt Idx Inv1.05M2.66%-22.94K
Wasatch Micro Cap646.90K1.68%646.90K
Wasatch Ultra Growth544.27K1.42%544.27K
Vanguard Institutional Extnd Mkt Idx Tr310.52K0.79%-141.50K
DFA US Small Cap I88.44K0.23%3.34K
BlackRock Extended Equity Market K67.36K0.18%-29.00
Bridgeway Ultra-Small Company Market67.00K0.17%-62.18K
iShares Micro-Cap ETF66.82K0.17%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 02, 2026San Martin Javier CHIEF MEDICAL OFFICERSell$11.31K
Jan 02, 2026Litton Mark James President and CEOSell$17.79K
Jan 02, 2026Renninger Robert Chief Financial OfficerSell$2.04K
Jan 02, 2026CHURCH KEVIN CHIEF SCIENTIFIC OFFICERSell$6.03K
Jan 02, 2026Worthington Mark General Counsel and CCOSell$6.03K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q3-5
2025 Q2--
2025 Q1-5
2024 Q4--

ATHA Ownership FAQ


Who Owns Athira Pharma?

Athira Pharma shareholders are primarily institutional investors at 11.57%, followed by 13.37% insiders and 75.06% retail investors. The average institutional ownership in Athira Pharma's industry, Biotech Stocks , is 384.56%, which Athira Pharma falls below.

Who owns the most shares of Athira Pharma?

Athira Pharma’s largest shareholders are Vanguard group (153.79K shares, 3.90%), Simplify asset management (149.28K shares, 3.79%), and Propel bio management (149.28K shares, 3.79%). Together, they hold 11.47% of Athira Pharma’s total shares outstanding.

Does Blackrock own Athira Pharma?

Yes, BlackRock owns 1.76% of Athira Pharma, totaling 676.24K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.79M$. In the last quarter, BlackRock increased its holdings by 8.97K shares, a 1.34% change.

Who is Athira Pharma’s biggest shareholder by percentage of total assets invested?

Propel bio management is Athira Pharma’s biggest shareholder by percentage of total assets invested, with 0.96% of its assets in 149.28K Athira Pharma shares, valued at 1.13M$.

Who is the top mutual fund holder of Athira Pharma shares?

Simplify Propel Opportunities ETF is the top mutual fund holder of Athira Pharma shares, with 3.79% of its total shares outstanding invested in 1.49M Athira Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools